4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-109447
Chief Legal Officer sold 4,430 shares at $5.98 ($26,491)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Mark Chief Legal Officer | 2024-09-25 | Sale 10b5-1 | −4,430 | $5.98 | $26,491 | 177,716 | D |
| Open-market sales · 4,430 sh · avg $5.98 · $26,491 | |||||||
Loading xslF345X05/ownership.xml…